"Invitae's Rapid Decline: From $7B Valuation to Near-Bankruptcy"

TL;DR Summary
Invitae Corporation, backed by SoftBank, is reportedly on the verge of filing for bankruptcy due to a substantial $1.5 billion debt burden. The company is seeking restructuring advice and legal counsel to navigate its financial challenges, while actively exploring strategic options including shedding assets and cost-cutting measures. SoftBank, having invested $1.2 billion in convertible debt in 2021, remains a stakeholder in the company, which has seen an 82% loss in market value over the past year.
- SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy Yahoo Finance
- Genetic test maker Invitae prepares for bankruptcy - WSJ Reuters
- SoftBank-Backed Medical Genetics Company Invitae Prepares for Bankruptcy The Wall Street Journal
- Invitae plunges amid report it may file for bankruptcy within weeks (NYSE:NVTA) Seeking Alpha
- Why Is Invitae (NVTA) Stock Down 75% Today? InvestorPlace
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
1 min
vs 2 min read
Condensed
76%
323 → 76 words
Want the full story? Read the original article
Read on Yahoo Finance